VCTS chart evaluation as a screening test
โ Scribed by P. C. Maudgal; R. W. O. Stout; A.Th.M. Balen
- Book ID
- 104650157
- Publisher
- Springer-Verlag
- Year
- 1988
- Tongue
- English
- Weight
- 400 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0012-4486
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
At this present time, we feel that there is no role for DNA flow cytometry (FCM), or indeed DNA studies by any other method, to be used as a screening procedure for patients with no prior history of bladder cancer due to the high false-positive rate found when monitoring exfoliated urothelial cells.
Reml~ At a cut-off of 20 mg/L, the Ivfioral-Test showed a poor senmtivity (56%). Correction for creafininc did incresee the sensitivity (69%) for the same specificity (98.7"A). The beat screening performance was obtained when the I~emI-Te=t results were expressed as rate 0tg/min) with a recciver-o~t